retatrutide clinical trial weight loss results New Phase 3 data just dropped 👀 Eli Lilly's reported average approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Retatrutide Phase 3: TRIUMPH Program

GLP-1 medications carry risks including pancreatitis, gallbladder disease, and potential thyroid C-cell tumours based on animal studies

But for something thats not even FDA-approved yet, like retatrutide, it is only for research purposes, explains Annie Lambert, a pharmacist and compounding specialist with Wolters Kluwer

March 25, 2025 15:41 View More The Secret to Aging Powerfully Build Strength & Longevity with JJ Virgin The Secret to Aging Powerfully Build Strength & Longevity with JJ Virgin March 10, 2025 10:28 View More Managing PCOS: A Holistic Approach to Hormonal Health March 3, 2025 11:09 View More Advancing Thyroid Care: Minimally Invasive Treatments with Jonathon O

Reducing cellulite helps you achieve smoother, more even skin